LenioBio is a life science biotech company offering a disruptive protein expression technology. ALiCE® enables the discovery, development and production of difficult-to-express proteins. The ALiCE® technology represents an eukaryotic cell-free protein expression platform that is scalable and changes the way proteins are produced today, across all industries.

If you are a scientist being active in protein expression and want to produce difficult-to-express proteins or increase yields, efficiency or scalability, LenioBio’s ALiCE® technology is the right option. Our technology is available in kits as well as a Protein Service that can be ordered directly from the scientist.com platform.

By ordering the feasibility expression study for cytosolic or microsomal/membrane proteins you will get the quick and well-founded information if expression of your proteins of interest is feasible.